Theravance Biopharma Inc.

8.52
0.20 (2.40%)
At close: Apr 09, 2025, 3:59 PM
8.43
-1.08%
Pre-market: Apr 10, 2025, 08:38 AM EDT

Theravance Biopharma Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for TBPH stock have an median target of 12.5, with a low estimate of 9 and a high estimate of 21. The median target predicts an increase of 46.71% from the current stock price of 8.52.

Target Low Average Median High
Price $9 $13.75 $12.5 $21
Change 5.63% 61.38% 46.71% 146.48%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating on Ther... Unlock content with Pro Subscription

Updated Feb 27, 2025

Rating Apr 24May 24Aug 24Sep 24Feb 25
Strong Buy 00000
Buy 12112
Hold 00200
Sell 00000
Strong Sell 00000
Total 1 2 3 1 2

Financial Forecast this Year

Revenue This Year
103.26M
from 64.38M
Increased by 60.4%
Revenue Next Year
86.7M
from 103.26M
Increased by -16%
EPS This Year
-0.18
from -1.15
Increased by 84.3%
EPS Next Year
-1.01
from -0.18
Increased by -461.1%